Thielen FW - Search Results

1

The administration of immune checkpoint inhibitors via an elastomeric pump versus conventional intravenous infusion: an economic perspective.

Zietse M, Malmberg R, van Leeuwen RWF, Thielen FW, Uyl-de Groot CA. Zietse M, et al. Among authors: thielen fw. BMC Health Serv Res. 2024 Oct 31;24(1):1322. doi: 10.1186/s12913-024-11719-0. BMC Health Serv Res. 2024. PMID: 39482711 Free PMC article.

2

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab.

Heine RJSD, Thielen FW, Mathijssen RHJ, van Leeuwen RWF, Franken MG, Uyl-de Groot CA. Heine RJSD, et al. Among authors: thielen fw. PLoS One. 2024 Feb 1;19(2):e0293264. doi: 10.1371/journal.pone.0293264. eCollection 2024. PLoS One. 2024. PMID: 38300937 Free PMC article.

3

Using Appropriate Methods in Cost-Effectiveness Analyses: The Case of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease.

Thielen FW, Blommestein HM, Uyl-de Groot CA. Thielen FW, et al. Biol Blood Marrow Transplant. 2016 Nov;22(11):2109-2110. doi: 10.1016/j.bbmt.2016.08.022. Epub 2016 Sep 13. Biol Blood Marrow Transplant. 2016. PMID: 27638364 Free article. No abstract available.

4

Cost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view.

Thielen FW, van Dongen-Leunis A, Arons AMM, Ladestein JR, Hoogerbrugge PM, Uyl-de Groot CA. Thielen FW, et al. Eur J Haematol. 2020 Aug;105(2):203-215. doi: 10.1111/ejh.13427. Epub 2020 May 4. Eur J Haematol. 2020. PMID: 32289184 Free PMC article.

5

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future.

Heine R, Thielen FW, Koopmanschap M, Kersten MJ, Einsele H, Jaeger U, Sonneveld P, Sierra J, Smand C, Uyl-de Groot CA. Heine R, et al. Among authors: thielen fw. Hemasphere. 2021 Jan 28;5(2):e524. doi: 10.1097/HS9.0000000000000524. eCollection 2021 Feb. Hemasphere. 2021. PMID: 33880433 Free PMC article.

6

Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease.

Leeneman B, Blommestein HM, van Dongen-Leunis A, Algeri M, Fibbe WE, Oosten L, Uyl-de Groot CA, Thielen FW. Leeneman B, et al. Among authors: thielen fw. Eur J Haematol. 2023 Aug;111(2):240-246. doi: 10.1111/ejh.13987. Epub 2023 May 3. Eur J Haematol. 2023. PMID: 37137484

7

Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model.

Thielen FW, Blommestein HM, Oosten LEM, Calkoen FG, Lankester AC, Zwaginga JJ, Le Blanc K, Redondo A, Sánchez-Guijo F, Algeri M, Locatelli F, Fibbe WE, Uyl-de Groot CA. Thielen FW, et al. Eur J Haematol. 2018 Aug 6. doi: 10.1111/ejh.13158. Online ahead of print. Eur J Haematol. 2018. PMID: 30084111

8

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.

Oosten LEM, Chamuleau MED, Thielen FW, de Wreede LC, Siemes C, Doorduijn JK, Smeekes OS, Kersten MJ, Hardi L, Baars JW, Demandt AMP, Stevens WBC, Nijland M, van Imhoff GW, Brouwer R, Uyl-de Groot CA, Kluin PM, de Jong D, Veelken H. Oosten LEM, et al. Among authors: thielen fw. Ann Hematol. 2018 Feb;97(2):255-266. doi: 10.1007/s00277-017-3167-7. Epub 2017 Dec 6. Ann Hematol. 2018. PMID: 29209924 Free PMC article.

9

Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma.

Bakker LJ, Thielen FW, Redekop WK, Groot CU, Blommestein HM. Bakker LJ, et al. Among authors: thielen fw. BMC Med Res Methodol. 2023 May 29;23(1):132. doi: 10.1186/s12874-023-01952-2. BMC Med Res Methodol. 2023. PMID: 37248477 Free PMC article.

10

Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis.

Wijnen BFM, Thielen FW, Konings S, Feenstra T, Van Der Gaag M, Veling W, De Haan L, Ising H, Hiligsmann M, Evers SMAA, Smit F, Lokkerbol J. Wijnen BFM, et al. Among authors: thielen fw. Expert Rev Pharmacoecon Outcomes Res. 2020 Jun;20(3):269-279. doi: 10.1080/14737167.2019.1632194. Epub 2019 Jun 20. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31195900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters